For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) was $1.23 for the day, up 8.85% from the previous closing price of $1.13. In other words, the price has increased by $8.85 from its previous closing price. On the day, 0.84 million shares were traded. ZNTL stock price reached its highest trading level at $1.25 during the session, while it also had its lowest trading level at $1.09.
Ratios:
Our analysis of ZNTL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.32 and its Current Ratio is at 7.32. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 ’25 when Bruns Ingmar bought 20,000 shares for $2.28 per share. The transaction valued at 45,656 led to the insider holds 36,629 shares of the business.
Cam Gallagher bought 687 shares of ZNTL for $1,374 on Feb 11 ’25. On Feb 03 ’25, another insider, Vultaggio Vincent, who serves as the PAO and Interim PFO of the company, sold 2,615 shares for $1.71 each. As a result, the insider received 4,476 and left with 189,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 88328152 and an Enterprise Value of -240106848. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.31 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at -3.561 whereas that against EBITDA is 1.29.
Stock Price History:
The Beta on a monthly basis for ZNTL is 1.87, which has changed by -0.9073097 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, ZNTL has reached a high of $14.50, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is -33.41%, while the 200-Day Moving Average is calculated to be -58.66%.
Shares Statistics:
ZNTL traded an average of 1.69M shares per day over the past three months and 923970 shares per day over the past ten days. A total of 71.28M shares are outstanding, with a floating share count of 54.00M. Insiders hold about 24.81% of the company’s shares, while institutions hold 86.95% stake in the company. Shares short for ZNTL as of 1743379200 were 4769777 with a Short Ratio of 2.82, compared to 1740700800 on 5174424. Therefore, it implies a Short% of Shares Outstanding of 4769777 and a Short% of Float of 13.270001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
